Human Chorionic Gonadotropin (HCG) Market, by Product Type (Human Chorionic Gonadotropin and Recombinant Human Chorionic Gonadotropin), by Therapeutic Application (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Tre

Human Chorionic Gonadotropin (HCG) Market, by Product Type (Human Chorionic Gonadotropin and Recombinant Human Chorionic Gonadotropin), by Therapeutic Application (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Human chorionic gonadotropin (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males, mostly to increase the sperm count and in young boys due to pituitary gland disorders and other diseases, owing to which the testicles of the young males do not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects. The hormone stimulates the corpus luteum to produce progesterone to maintain the pregnancy.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and acquisitions by the key players in the market is expected to drive the market growth over the forecast period. For instance, in January 2021, Merck & Co., Inc., a science and technology company announced a multi-year partnership with Royal Philips, which is a health technology company, to develop clinical-grade digital solutions for highly personalized fertility treatment.

Key features of the study:

• This report provides an in-depth analysis of the global human chorionic gonadotropin (HCG) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global human chorionic gonadotropin (HCG) market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies.
• Key companies covered as a part of this study includes Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd, Lee BioSolutions, Serum Institute of India Pvt. Ltd., Scripps Laboratories, Sanzyme Biologics Pvt. Ltd., VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human chorionic gonadotropin (HCG) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human chorionic gonadotropin hormone (HCG) market.

Detailed Segmentation:

• Global Human chorionic gonadotropin hormone (HCG) Market, By Product Type:
• Human Chorionic Gonadotropin
• Recombinant Human Chorionic Gonadotropin
• Global Human chorionic gonadotropin hormone (HCG) Market,, By Therapeutic Application:
• Male Hypogonadism
• Female Infertility Treatment
• Oligospermic Treatment
• Cryptorchidism Treatment
• Chronic Pain
• Others
• Global Human chorionic gonadotropin hormone (HCG) Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Human chorionic gonadotropin hormone (HCG) Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Merck & Co., Inc.,*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Ferring B.V.,
• Fresenius SE & Co.KGaA
• Lupin
• Sun Pharmaceutical Industries Ltd
• Lee BioSolutions
• Serum Institute of India Pvt. Ltd.,
• Scripps Laboratories
• Sanzyme Biologics Pvt.
• VHB Medi Sciences Limited
• Bharat Serums And Vaccines Limited (BSV)
• Zydus Lifesciences Ltd
• Corona Remedies Pvt. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.